PiperJaffray Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $7

PiperJaffray maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Neutral and raises the price target from $6 to $7.

Benzinga · 11/08/2019 14:40

PiperJaffray maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Neutral and raises the price target from $6 to $7.